Nov 21 2024
According to a new study, marijuana-based medicines show promise in treating peripheral neuropathy, a chronic and debilitating condition often resistant to traditional nonsurgical treatments. The study, conducted by researchers from the University of Virginia, explored the potential of cannabis-based medications for managing pain and symptoms associated with peripheral neuropathy, including cases caused by nerve injury, …
Nov 20 2024
A study published in Clinical Parkinsonism & Related Disorders has found that the vast majority of those in France with Parkinson’s disease support medical marijuana and CBD use. In France, cannabis use is illegal outside the current restricted medical cannabis experimental framework which does not include Parkinson’s disease (PD) as an eligible condition. In contrast, …
Nov 19 2024
Lifetime cannabis use does not appear to negatively impact cognitive decline, and may actually protect against it, according to a longitudinal study published in Brain and Behavior. The research assessed the relationship between marijuana use and age-related cognitive changes in a cohort of 5,162 Danish men over a span of 44 years. Participants’ IQs were …
Nov 18 2024
According to a new study, hemp extract containing cannabidiol (CBD) and cannabidiolic acid (CBDA) may help mitigate the cognitive impairments and brain inflammation associated with chronic stress. Published in the Journal of Ethnopharmacology and conducted by researchers at Mae Fah Luang University, the study provides new insights into hemp’s potential neuroprotective properties. The researchers explored …
Nov 15 2024
A new systematic review from Utrecht University in the Netherlands explores the potential of minor cannabinoids in treating psychiatric disorders. Published in European Neuropsychopharmacology, the study offers fresh insight into how these lesser-known compounds might aid in addressing conditions such as anxiety, depression, and addiction. The research highlights the growing interest in cannabinoids for mental …
Nov 14 2024
Researchers at University Hospital of the Technical University of Munich have found that cannabidiol (CBD) may help protect lung endothelial cells from the harmful side effects of radiation, which they outline in a new study. Published in the journal Cancers, the study investigated CBD’s ability to shield the lung’s microvasculature from oxidative stress and inflammation …
Nov 13 2024
A new study conducted by researchers from Augusta University and The University of Texas Health Science Center at Houston has found that cannabidiol (CBD) may serve as a promising, cost-effective treatment for Alzheimer’s disease (AD). Published in the International Journal of Molecular Sciences, the study suggests that inhaled CBD could help improve cognitive function and …
Nov 07 2024
A study published in Plastic and Reconstructive Surgery has found that marijuana use does not significantly impact outcomes in breast reduction surgeries. Conducted by researchers from the University of Pennsylvania and NYU Langone, the study aimed to clarify whether marijuana use might influence surgical outcomes or quality of life (QoL) post-surgery, as marijuana use continues …
Nov 02 2024
A new study published in AJOB Neuroscience reveals that most Americans support psilocybin use under supervision, with broad bipartisan backing for both mental health treatment and general well-being enhancement. Psilocybin, the psychedelic compound found in “magic mushrooms”, remains classified as a Schedule I substance in the U.S., making it illegal for all uses, despite numerous …
Oct 31 2024
According to a newly published meta-analysis, “psilocybin is superior in treating depression compared to established psychotherapy alone used for treating depression.” Published in the Journal of Psychopharmacology, the study was conducted by researchers from Alborz University of Medical Sciences, Tehran University of Medical Sciences, and Shahid Beheshti University of Medical Sciences, all in Iran. “Due …
